GB-88 is an oral, selective non-peptide antagonist of PAR2. It inhibits PAR2 activated Ca2+ release with an IC50 of 2 µM.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | GB-88 is an orally active, selective non-peptide PAR2 antagonist that inhibits PAR2-activated Ca2+ release with an IC50 of 2 µM[1].GB-88 inhibits iCa2+ release induced by trypsin, 2f-LIGRLO-NH2 and GB110 (PAR2 agonist) in HT29 cells. The antagonistic effect of GB-88 is agonist dependent[1]. |
Animal study | Administered orally in olive oil at a dose of 10 mg/kg, GB-88 possesses oral and in vivo anti-inflammatory activity, with specific antagonistic activity against four structurally and mechanistically distinct PAR2 agonists (2f-LIGRLO-NH2, trypsin, SLIGRL-NH2 and GB110). GB-88 inhibits PAR2-induced acute inflammation in a rat model in vivo[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.83mL 0.37mL 0.18mL |
9.15mL 1.83mL 0.91mL |
18.29mL 3.66mL 1.83mL |
CAS号 | 1416435-96-5 |
分子式 | C32H42N4O4 |
分子量 | 546.7 |
别名 | |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,Store in freezer, under -20°C |
溶解度 |
DMSO: 30 mg/mL(54.87 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |